ArticleBriefings in bioinformatics2026
Exploring potential transcription factors and their regulatory relationships based on asymmetric covariance natural vector encoding method and machine learning algorithms.
Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Transcription factors (TFs) orchestrate cellular programs by activating or repressing gene expression in response to diverse stimuli. Although advances in experimental and computational biology have expanded our understanding of TFs, existing prediction methods still struggle to accurately capture TF-target regulatory relationships and determine their directionality (activation versus inhibition). Here, we propose ACNVE-K, an integrative framework combining k-mer decomposition with asymmetric covariance natural vector encoding to convert amino acid sequences into multidimensional feature vectors. Using Leveraging eXtreme Gradient Boosting (XGBoost), Gradient Boosting (GB), and Random Forest (RF) algorithms, we constructed five predictive models for TF identification, target gene inference, and regulatory direction classification. Benchmarking analyses demonstrated that XGBoost achieved the highest predictive performance across human and mouse genomes, particularly with updated genome annotations. The 5-mer configuration provided an optimal balance between feature richness and computational efficiency. Collectively, ACNVE-K offers a robust and interpretable framework for decoding transcriptional regulation, facilitating advances in precision medicine, regulatory genomics, and machine-learning-based gene network reconstruction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.